STOCK-BASED COMPENSATION (Details Narrative) $ in Millions |
6 Months Ended |
|---|---|
|
Jun. 30, 2023
USD ($)
shares
| |
| Stock Options [Member] | |
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |
| Compensation cost related to non-vested options not recognized | $ 2.0 |
| Weighted average vesting period | 1 year 8 months 12 days |
| Restricted Stock [Member] | |
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |
| Weighted average vesting period | 2 years 6 months |
| Unrecognized compensation expense | $ 9.7 |
| Fair value of restricted stock awards that vested | $ 0.6 |
| 2023 Incentive Plan [Member] | |
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |
| Shares available for grant | shares | 149,291 |
| X | ||||||||||
- Definition ShareBased payment award other than options vested in period fair value. No definition available.
|
| X | ||||||||||
- Definition Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of cost to be recognized for option under share-based payment arrangement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|